Evidence map›Paper›PMID 40400998›Full record

ArticleAmerican journal of clinical and experimental urology2025

Akram Mirzaei, Diana Taheri, Behrouz Fattahi, Farshid Alaeddini, Helia Azodian Ghajar, Leonardo Oliveira Reis, Seyed Mohammad Kazem Aghamir

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of clinical and experimental urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Akram MirzaeiUrology Research Center, Tehran University of Medical Sciences Tehran, Iran.
Diana TaheriUrology Research Center, Tehran University of Medical Sciences Tehran, Iran.
Behrouz FattahiAlborz University of Medical Sciences Karaj, Iran.
Farshid AlaeddiniTehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences Tehran, Iran.
Helia Azodian GhajarUrology Research Center, Tehran University of Medical Sciences Tehran, Iran.
Leonardo Oliveira ReisUroScience, State University of Campinas, Unicamp and Pontifical Catholic University of Campinas, PUC-Campinas Campinas, Sao Paulo State, Brazil.
Seyed Mohammad Kazem AghamirUrology Research Center, Tehran University of Medical Sciences Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study aimed to investigate the expression of

methodsIn a prospective study, we examined 40 patients who had been diagnosed with bladder cancer. The diagnosis was confirmed through cystoscopy, biopsy, and histopathology. We used the RT-PCR method to measure the levels of human

resultsThe study revealed a significant correlation between patients' histological grades and muscle invasiveness. Additionally, the investigation of 5 isoforms in patients showed that

conclusionsThe relationship between the grade of bladder cancer and the two isoforms of SPP1A and VEGFC shows that these indicators could help pathologists differentiate between high and low-grade bladder cancer and potentially be used as predictive markers.

Indexed as

bladder cancerinvasivenessSPP1tumor gradeVEGF

Identifiers

PMID40400998
PMCPMC12089228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.